Pharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.
Mark Borns, PharmD
Advertisement
Articles by Mark Borns, PharmD
Pharmacists need to be experts on follow-on biologics, including biosimilars, so they can provide education to health professionals about safe prescribing and use.
Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.
Advertisement
Latest Updated Articles
Biosimilars and Follow-on Biologics: A Pharmacist OpportunityNovember 16th 2016
Biosimilars and Follow-on BiologicsSeptember 28th 2017
Biosimilars and Follow-on Biologics: A Pharmacist OpportunityOctober 12th 2016
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
3
Thoracic Radiotherapy Added to Atezolizumab Raises Fatal Toxicity Risk in ES-SCLC
4
Up to 5 Cups of Coffee Daily Safe—and Beneficial—for Most Adults
5